STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype

Carminia Maria Della Corte(University of Campania "Luigi Vanvitelli"), Triparna Sen(The University of Texas MD Anderson Cancer Center), Carl M. Gay(The University of Texas MD Anderson Cancer Center), Kavya Ramkumar(The University of Texas MD Anderson Cancer Center), Lixia Diao(The University of Texas MD Anderson Cancer Center), Robert J. Cardnell(The University of Texas MD Anderson Cancer Center), B. Leticia Rodriguez(The University of Texas MD Anderson Cancer Center), C. Allison Stewart(The University of Texas MD Anderson Cancer Center), Vassiliki A. Papadimitrakopoulou(The University of Texas MD Anderson Cancer Center), Laura Gibson(The University of Texas MD Anderson Cancer Center), Jared J. Fradette(The University of Texas MD Anderson Cancer Center), Qi Wang(The University of Texas MD Anderson Cancer Center), You-Hong Fan(The University of Texas MD Anderson Cancer Center), David H. Peng(The University of Texas MD Anderson Cancer Center), Marcelo V. Negrão(The University of Texas MD Anderson Cancer Center), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Junya Fujimoto(The University of Texas MD Anderson Cancer Center), Luisa M. Solis Soto(The University of Texas MD Anderson Cancer Center), Carmen Behrens(The University of Texas MD Anderson Cancer Center), Ferdinandos Skoulidis(The University of Texas MD Anderson Cancer Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Jing Wang(The University of Texas MD Anderson Cancer Center), Don L. Gibbons(The University of Texas MD Anderson Cancer Center), Lauren A. Byers(The University of Texas MD Anderson Cancer Center)
Journal of Thoracic Oncology
February 14, 2020
Cited by 202Open Access
Full Text

Abstract


Related Papers